ArticleBMJ open2022

Prevention of vasoplegia with CytoSorb in heart failure patients undergoing cardiac surgery (CytoSorb-HF trial): protocol for a randomised controlled trial.

Olga Papazisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.